Dianthus Therapeutics Inc <DNTH.O>: JPMorgan initiates coverage with overweight rating; price target $135
DNTH•Related News
MiniMed grants director Amy Bricker 11,877 restricted stock units
MMED•
TuHURA Biosciences draws $650,000 under Parkview Holdings One credit facility
HURA•
Costco sets fiscal 2027 CEO base bonus at $1.2 million
COST•
TScan Therapeutics directors Garry Nicholson and Gabriela Gruia resign
TCRX•
Cadence Design Systems senior vice president Paul Cunningham reports sale of $648,260 in common shares
CDNS•